"As we seek to ‘transform innovation into impact’ UHN's office of Technology Development and Commercialization aims to translate UHN research discoveries into patient benefit and economic impact by facilitating the commercialization of new healthcare products and services."
- Dr. Brian H. Barber, Director, Technology Development and Commercialization
RaySearch Licenses Groundbreaking Technology from Princess Margaret Hospital
International Malaria Research Consortium Combines Technologies and Expertise From Two Continents to Tackle Deadly Disease .
UHN Drug Discovery licensed to APEIRON Biologics to be developed by GlaxoSmithKline.
A New Handheld Optical Molecular Imaging Platform for Wound Care and Other Applications
Conducting groundbreaking cancer research at the Princess Margaret Hospital, part of University Health Network (UHN), Dr. Fei-Fei Liu has recently published her work in the prestigious journal Science Translational Medicine.